Oscar Health, Inc. (OSCR)

US — Healthcare Sector
Peers: ACLX  NAMS  AKRO  HNGE  ALHC  OPCH  KYMR  IMVT  TMDX  VKTX 

Automate Your Wheel Strategy on OSCR

With Tiblio's Option Bot, you can configure your own wheel strategy including OSCR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol OSCR
  • Rev/Share 44.198
  • Book/Share 4.0208
  • PB 3.6439
  • Debt/Equity 0.6702
  • CurrentRatio 0.9461
  • ROIC -0.132

 

  • MktCap 3731671590.0
  • FreeCF/Share 2.8801
  • PFCF 5.0727
  • PE -15.2883
  • Debt/Assets 0.1194
  • DivYield 0
  • ROE -0.2156

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 2
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation OSCR Goldman -- Neutral -- $17 Oct. 14, 2025
Downgrade OSCR Robert W. Baird Outperform Neutral -- $14 July 25, 2025
Downgrade OSCR UBS Neutral Sell -- $11 July 15, 2025
Downgrade OSCR Piper Sandler Overweight Neutral -- $14 July 14, 2025
Downgrade OSCR Wells Fargo Equal Weight Underweight -- $10 July 11, 2025
Initiation OSCR Barclays -- Underweight -- $17 July 2, 2025
Downgrade OSCR Raymond James Outperform Market Perform -- -- June 24, 2025
Downgrade OSCR Wells Fargo Overweight Equal Weight $20 $16 March 13, 2025
Initiation OSCR Jefferies -- Underperform -- $12 Dec. 10, 2024
Initiation OSCR UBS -- Neutral -- $23 Oct. 7, 2024

News

Oscar Health, Inc. (OSCR) Increases Despite Market Slip: Here's What You Need to Know
OSCR
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Negative

In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $13.61, indicating a +1.8% shift from the previous trading day.

Read More
image for news Oscar Health, Inc. (OSCR) Increases Despite Market Slip: Here's What You Need to Know
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
OSCR
Published: March 05, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)--Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX Ventures with participation from Floating Point, Thiel Bio, Founders Fund, Bertelsmann Investments, and existing investors, Giant Ventures and Obvious Ventures. The round also received backing from angel investors and healthcare pioneers, including Mario Schlosser, co-founder and former CEO of Oscar Health (NYSE: OSCR), Ryan Fukushima, COO of Tempus,.

Read More
image for news Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
Shareholders That Lost Money on Oscar Health, Inc. (OSCR) Should Contact Levi & Korsinsky About Securities Fraud Investigation - OSCR
OSCR
Published: February 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning possible violations of federal securities laws. Oscar Health reported mixed earnings performance for the fourth quarter including a greater than expected loss of $0.62 per share.

Read More
image for news Shareholders That Lost Money on Oscar Health, Inc. (OSCR) Should Contact Levi & Korsinsky About Securities Fraud Investigation - OSCR
Shareholder Rights Advocates at Levi & Korsinsky Investigate Oscar Health, Inc. (OSCR) Regarding Possible Securities Fraud Violations
OSCR
Published: February 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning possible violations of federal securities laws. Oscar Health reported mixed earnings performance for the fourth quarter including a greater than expected loss of $0.62 per share.

Read More
image for news Shareholder Rights Advocates at Levi & Korsinsky Investigate Oscar Health, Inc. (OSCR) Regarding Possible Securities Fraud Violations
Michael Burry's latest stock bet is skyrocketing
OSCR
Published: February 19, 2025 by: Finbold
Sentiment: Positive

Michael Burry of ‘The Big Short' fame earned the admiration of investors all over the world by correctly predicting and profiting off of the 2008 subprime mortgage crisis.

Read More
image for news Michael Burry's latest stock bet is skyrocketing
Oscar Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - OSCR
OSCR
Published: February 13, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Oscar Health, Inc. ("Oscar Health" or "the Company") (NYSE: OSCR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.

Read More
image for news Oscar Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - OSCR

About Oscar Health, Inc. (OSCR)

  • IPO Date 2021-03-03
  • Website https://www.hioscar.com
  • Industry Medical - Healthcare Plans
  • CEO Mark Thomas Bertolini
  • Employees 2400

Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.